ISSN: 2167-0846

痛みと緩和のジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • Jゲートを開く
  • Genamics JournalSeek
  • コスモスIF
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

High-frequency Spinal Cord Stimulation as a Palliative Treatment for Patients with Low Back and Lower Extremity Radiated Chronic Pain

Alcobia-Diaz B, Luque-Perez R, Urda Martínez-Aedo A, Noriega-Bastos M, Domínguez-Esteban I and Marco Martínez F

Introduction: Since "Gate Control" theory was published, Spinal Cord Stimulation (SCS) has been used in palliative management of Low-back Pain (LBP) and lower extremity Radiated Pain (RP) and functionality in patients with Lumbar Stenosis (LS), Degenerative Scoliosis (DS) or Failed Back Surgery Syndrome (FBSS). Our aim is to describe our experience with High Frequency Spinal Cord Stimulation (HF-SCS).
Methods: Descriptive, retrospective study (n=30) between 2014-2017 with HF-SCS due to intractable LBP and RP. Mean age was 69 (45-87), mean Comorbidity Charlson Index (CCI) was 6; 80% female with minimum follow up of 12 months. Items reviewed were time to implantation, VAS for LBP and RP and Owestry disability index (ODI), improvement in hungry, emotional status or sleeping; and personal satisfaction. Complications related to procedure were also recorded.
Results: HF-SCS was indicated in 25% patients because of LBP and LERP secondary to LS or not operable DS. Median time to surgery was 3 years (ICR 1-6). Pre and post-surgery mean (SD) values were VAS-LBP 8.63 (1.09) 4.43 (2.5); VAS-LERP 7.03 (2.84) 4.77 (2.49); and ODI 67.2 (11.9) 48.33 (16.93). All of these were statistically significant (p<0.01); 60% improved in sleeping and mood. No patient presented lower limbs paraesthesia, but 13% had electrodes mobilization. 73% were finally satisfied with treatment received.
Conclusion: HF-SCS use for refractory LB and RP could be an effective tool to improve patient pain and functionality with high satisfaction. Especially in those who are not candidates for corrective surgery because of their age or comorbidities.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。